FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
6 letters match. Newest first.
-
DrugsNana Barseghian, M.D.
FDA warns clinical investigator Nana Barseghian for enrolling high-body-mass-index subjects in drug trials despite protocol exclusion.
High risk -
DrugsMehran Michael Bahrami, M.D.
FDA warns clinical investigator Dr. Mehran Michael Bahrami over protocol violations and missing records in investigational drug trials.
High risk -
DrugsDaniel Fred Goodman, M.D./Goodman Eye Center
FDA warns Dr. Daniel Fred Goodman/Goodman Eye Center over clinical drug study without required FDA application and missing consent/assent.
High risk -
DrugsSmitha C. Reddy, M.D./ACRC Studies, LLC
FDA warns Dr. Smitha Reddy over clinical trial protocol violations, including wrong drug given and broken blinding.
High risk -
Drugs"Daniel C. Tarquinio, D.O./Center for Rare Neurological Diseases
FDA warns clinical investigator Daniel C. Tarquinio over enrolling ineligible subjects in investigational drug trials.
High risk -
DrugsRichard J. Obiso, PhD dba Avila Herbals, LLC
FDA warns Avila Herbals and investigator over drug trial lacking required FDA application, ethics review, and consent.
High risk